BackSkye Bioscience Overview

Skye Bioscience Current Assets

Track Skye Bioscience's current assets ($19M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$18.57M
↓ 99.97% YoYΔ $-63.01B vs prior year quarter

Peer trimmed avg / median

Loading

Skye Bioscience Current Assets History

Loading

Skye Bioscience vs. peers: Current Assets Comparison

Loading

Skye Bioscience Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Skye Bioscience (SKYE) FAQ

As of the most recent data (March 2026), SKYE shows a current assets of $19M. That compares with $63B in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SKYE's current assets is now $19M (was $63B) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Skye Bioscience is outperforming or lagging.

Tracking SKYE's current assets over time shows whether Skye Bioscience is scaling, shrinking, or reshaping that part of the business. The current reading is $19M That compares with $63B in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Skye Bioscience's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $19M) with ownership activity and broader fundamentals.